Pan -India Drugs & Chemicals Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 6.99 Cr
- Company Age 32 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.01 M
- Revenue Growth -8.31%
- Profit Growth -9.22%
- Ebitda -41.01%
- Net Worth 2.29%
- Total Assets 2.27%
About Pan -India Drugs & Chemicals
Pan -India Drugs & Chemicals Limited (PIDCL) is a Public Limited Indian Non-Government Company incorporated in India on 26 March 1992 and has a history of 32 years and ten months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 6.99 Cr.
The company currently has active open charges totaling ₹8.01 M.
Lalitchandra Shah, Harshit Shah, and Ashish Shah serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232MP1992PLC007026
-
Company No.
007026
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
26 Mar 1992
-
Date of AGM
30 Jul 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Pan -India Drugs & Chemicals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalitchandra Shah
|
Director | 06-Nov-2006 | Current |
|
Harshit Shah
|
Director | 07-Jan-2016 | Current |
|
Ashish Shah
|
Director | 31-Aug-2012 | Current |
Financial Performance of Pan -India Drugs & Chemicals.
Pan -India Drugs & Chemicals Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 8.31% decrease. The company also saw a slight decrease in profitability, with a 9.22% decrease in profit. The company's net worth moved up by a moderate rise of 2.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pan -India Drugs & Chemicals?
In 2020, Pan -India Drugs & Chemicals had a promoter holding of 0.14% and a public holding of 99.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Jaina Windpark Private LimitedHarshit Shah is a mutual person
-
Nutan Plastic Works Private Limited
Ashish Shah is a mutual person
Charges (Loans)
₹0.80 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.46 Cr
- Madhya Pradesh Financial Corporation Finance : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jul 1994 | State Bank Of India | ₹4.55 M | Open |
| 29 Sep 1993 | Madhya Pradesh Financial Corporation Finance | ₹3.46 M | Open |
How Many Employees Work at Pan -India Drugs & Chemicals?
Unlock and access historical data on people associated with Pan -India Drugs & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pan -India Drugs & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pan -India Drugs & Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
